Extract:
Based on this comprehensive report published by Gravitas Market Insights, the Next-Generation Sequencing market is said to witness a significant growth during the forecast years between 2021 and 2028. Next-Generation Sequencing diagnostic technology has the potency to decide the genetic sequence of a virus and assist scientists in comprehending the virus mutations. Ever since the COVID-19 pandemic, across the globe several government establishments are round-the-clock working with the private sector to get NGS technology as the diagnostic tool in the market.
Report Scope in detail:
This latest report edition of Next-Generation Sequencing market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Next-Generation Sequencing market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years.
Market Dynamics:
- In developed countries, biopharmaceutical and pharmaceutical companies are using more and more of NGS technology.
- In Europe and North America research and development activities are on the rise.
- In the regional aspect, North America is predicted to gain maximum CAGR during the forecast period, this is owing to the rising occurrence of genetic and cancer diseases. Also, North America has a favourable regulatory scenario.
- Besides, higher cost of next generation sequencing is said to hinder the market growth.
Next-Generation Sequencing Market Segmentation:
By Type of Sequencing
- Targeted Resequencing
- Whole Genome Sequencing
- CHIP Sequencing
- Whole Exome Sequencing
- RNA Sequencing
- De Novo Sequencing
- Methyl Sequencing
By Product
- Reagents and Consumables
- Instruments
- Services
By Application
- Drug Discovery and Personalized Medicine
- Diagnostics
- Genetic Screening
- Agriculture and Animal Research
- Others
By End Use
- Hospitals and Healthcare Institutions
- Pharmaceutical and Biotechnology Companies
- Academics & Research
Regional Coverage
- North America
- United States
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Competitive Analysis:
Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.
Few of the Key Players Covered in Our Report:
- Bio-Rad Laboratories Inc.
- Agilent Technologies
- Eurofins Scientific
- DNASTAR Inc.
- Macrogen Inc.
- F. Hoffmann-La Roche Ltd
- Illumina Inc.
- Pacific Biosciences of California Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Qiagen
Impact of COVID19:
The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
Section 1: Executive Summary
1.1. Next-Generation Sequencing Market Industry 360° outline, Year 2016 – 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. End-User/Product Trends
1.5. Regional Trends
Section 2: Market Dynamics - Next-Generation Sequencing Market Industry Insights
2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter’s Analysis
2.6. Worldwide Industry Landscape, Year 2016 – 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape
2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa
2.10. Competitive Environment
Section 3: Global Next-Generation Sequencing Market, By Type of Sequencing
3.1. Segmentation Analysis, By Type of Sequencing, 2016-2028
3.2. Market Share Segmentation Analysis, By Type of Sequencing, 2016-2028
3.3. Targeted Resequencing
3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.4. Whole Genome Sequencing
3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.5. CHIP Sequencing
3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.6. Whole Exome Sequencing
3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.7. RNA Sequencing
3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.8. De Novo Sequencing
3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.9. Methyl Sequencing
3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 4: Global Next-Generation Sequencing Market, By Product
4.1. Segmentation Analysis, By Product, 2016-2028
4.2. Market Share Segmentation Analysis, By Product, 2016-2028
4.3. Reagents and Consumables
4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.4. Instruments
4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.5. Services
4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 5: Global Next-Generation Sequencing Market, By Application
5.1. Segmentation Analysis, By Application, 2016-2028
5.2. Market Share Segmentation Analysis, By Application, 2016-2028
5.3. Drug Discovery and Personalized Medicine
5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4. Diagnostics
5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5. Genetic Screening
5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.6. Agriculture and Animal Research
5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.7. Others
5.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 6: Global Next-Generation Sequencing Market, By End Use
6.1. Segmentation Analysis, By End Use, 2016-2028
6.2. Market Share Segmentation Analysis, By End Use, 2016-2028
6.3. Hospitals and Healthcare Institutions
6.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.4. Pharmaceutical and Biotechnology Companies
6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.5. Academics & Research
6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 7: Global Next-Generation Sequencing Market, Regional Analysis
7.1. Global Next-Generation Sequencing Market, Regional Analysis
7.2. North America, Country level Analysis
7.2.1. North America Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Type of Sequencing, 2016 – 2028
7.2.2. North America Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Product, 2016 – 2028
7.2.3. North America Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
7.2.4. North America Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.2.5. United States
7.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.2.6. Canada
7.2.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.2.7. Mexico
7.2.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3. Europe Country level Analysis
7.3.1. Europe Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Type of Sequencing, 2016 – 2028
7.3.2. Europe Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Product, 2016 – 2028
7.3.3. Europe Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
7.3.4. Europe Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.3.5. UK
7.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.6. Germany
7.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.7. France
7.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.8. Italy
7.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.9. Spain
7.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.10. Russia
7.3.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.11. Rest of Europe
7.3.11.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4. Asia-Pacific Country level Analysis
7.4.1. Asia-Pacific Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Type of Sequencing, 2016 – 2028
7.4.2. Asia-Pacific Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Product, 2016 – 2028
7.4.3. Asia-Pacific Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
7.4.4. Asia-Pacific Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.4.5. China
7.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.6. India
7.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.7. Japan
7.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.8. Korea
7.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.9. Australia
7.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.10. Southeast Asia
7.4.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.11. Rest of Asia-Pacific
7.4.11.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.5. South America Country level Analysis
7.5.1. South America Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Type of Sequencing, 2016 – 2028
7.5.2. South America Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Product, 2016 – 2028
7.5.3. South America Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
7.5.4. South America Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.5.5. Brazil
7.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.5.6. Argentina
7.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.5.7. Colombia
7.5.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.5.8. Rest of South America
7.5.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.6. Middle East & Africa Country level Analysis
7.6.1. MEA Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Type of Sequencing, 2016 – 2028
7.6.2. MEA Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Product, 2016 – 2028
7.6.3. MEA Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By Application, 2016 – 2028
7.6.4. MEA Next-Generation Sequencing Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.6.5. GCC
7.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.6.6. South Africa
7.6.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.6.7. Rest of Middle East & Africa
7.6.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 8: Company Profile - Next-Generation Sequencing Market
8.1. Bio-Rad Laboratories Inc.
8.1.1. Business Overview
8.1.2. Product & Service Offering
8.1.3. Overall Revenue
8.1.4. Strategic Outlook
8.2. Agilent Technologies
8.2.1. Business Overview
8.2.2. Product & Service Offering
8.2.3. Overall Revenue
8.2.4. Strategic Outlook
8.3. Eurofins Scientific
8.3.1. Business Overview
8.3.2. Product & Service Offering
8.3.3. Overall Revenue
8.3.4. Strategic Outlook
8.4. DNASTAR Inc.
8.4.1. Business Overview
8.4.2. Product & Service Offering
8.4.3. Overall Revenue
8.4.4. Strategic Outlook
8.5. Macrogen Inc.
8.5.1. Business Overview
8.5.2. Product & Service Offering
8.5.3. Overall Revenue
8.5.4. Strategic Outlook
8.6. F. Hoffmann-La Roche Ltd
8.6.1. Business Overview
8.6.2. Product & Service Offering
8.6.3. Overall Revenue
8.6.4. Strategic Outlook
8.7. Illumina Inc.
8.7.1. Business Overview
8.7.2. Product & Service Offering
8.7.3. Overall Revenue
8.7.4. Strategic Outlook
8.8. Pacific Biosciences of California Inc.
8.8.1. Business Overview
8.8.2. Product & Service Offering
8.8.3. Overall Revenue
8.8.4. Strategic Outlook
8.9. Thermo Fisher Scientific Inc.
8.9.1. Business Overview
8.9.2. Product & Service Offering
8.9.3. Overall Revenue
8.9.4. Strategic Outlook
8.10. PerkinElmer Inc.
8.10.1. Business Overview
8.10.2. Product & Service Offering
8.10.3. Overall Revenue
8.10.4. Strategic Outlook
8.11. Qiagen
8.11.1. Business Overview
8.11.2. Product & Service Offering
8.11.3. Overall Revenue
8.11.4. Strategic Outlook
*Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028
*Details on financial performance and strategic moves and developments may not be captured for unlisted companies
*List of companies profiled in this TOC is tentative and may change after detailed analysis
